GNOMvsIBRN
Global X Genomics & Biotechnology ETF against iShares Neuroscience and Healthcare ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| GNOM | IBRN | |
|---|---|---|
| Expense ratio | 0.50% | 0.47% |
| Assets | $85M | $7864.21T |
| Net flow, 1 month | — | +$2M |
| Net flow, 1 year | — | +$2M |
| Return, YTD | +46.2% | +24.7% |
| Return, 1 year | +614.4% | +57.5% |
| Avg daily volume | 20K | 3K |
| Holdings | 41 | 54 |
| Listed | Apr 4, 2019 | Aug 23, 2022 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS